Index
Module 4 • Quality & Safety
Protocol Development & Quality Improvement
50%
Core Content
Protocol Development & Quality Improvement
Jaime Robenolt Gray ~3 min read Module 4 of 20
22
/ 44

Protocol Development and Quality Improvement

PROFESSION-FOCUSED RECOMMENDATIONS

D6. A scope of practice

including core competencies

should be developed and

defined for pharmacy

technicians in acute‑care and

ambulatory‑care settings.

C9. Pharmacy should employ

high‑reliability principles when

designing and selecting health

information technology.

C10. Pharmacy should advocate

for information technology that

is interoperable and transparent

with respect to usability,

security, and functionality

across the continuum of care.

C11. Pharmacy should establish

standards for the application

of artificial intelligence (AI)

in the various steps of the

medication‑use process,

including prescribing, reviewing

medication orders, and

assessing medication‑use

patterns in populations.

A14. Pharmacists should

lead and advocate for

comprehensive medication

management in all

healthcare settings.

B8. Pharmacy education,

residency training, and

continuing education should

cover healthcare reimbursement,

payment, and business

management in all areas of

practice.

B9. Pharmacists in all care

settings should be included

as integral members of the

healthcare team and share

accountability for patient

outcomes and population health.

B10. The pharmacy workforce

should be knowledgeable and

have the resources to care for

patients with behavioral and

mental health disorders.

B11. Training and credentialing

should exist to develop and

recognize pharmacists who

specialize in health information

technology.

B12. Credentialed ambulatory‑

care pharmacists should be

considered primary care

providers.

B13. The profession should

champion multi‑state or national

licensure for pharmacists.

B14. Pharmacists, in collaboration

with other key stakeholders,

must work to increase

public, regulatory, and health

professional understanding of

pharmacists’ roles and value.

E11. Pharmacists should lead the

development, implementation,

and evaluation of medication‑

related national quality

indicators and accountability

measures.

E12. Pharmacists should be

leaders in federal and state

legislative and regulatory

policy development related

to improving individual and

population health outcomes.

E13. Pharmacy should

partner with interprofessional

organizations to define and

delineate practice advances

into state and federal laws and

regulations to optimize patient

care.

E14. Pharmacy should leverage

healthcare models that

acknowledge pharmacist value

and align payment with quality

of outcomes.

Patient-Centered

Care

Pharmacy Technician

Role, Education, &

Training

Leadership in

Medication Use &

Safety

Pharmacist Role,

Education, &

Training

Technology

& Data Science

Figure 1. ASHP Practice Advancement Initiative 2030. (continued)

Used with permission from: American Society of Health-System Pharmacists (ASHP). PAI 2030 Recommendations. Available at https://www.ashp.org/Pharmacy-Practice/PAI/PAI-Recommendations.

HD Video Explanation β€” Synchronized with PDF
Starts at: minute 21 Open on YouTube